brentuximab vedotin
seagen,takeda
['t-cell lymphoma', 'peripheral t-cell lymphoma', 'hodgkin', 'ptcl', 'lymphoma', 'brentuximab', ' vedo']
how do certain care factors affect clinical outcomes for peripheral t-cell #lymphoma (#ptcl) patients? dr. jia ruan dives into data from the leo-mer cohorts and shares insights in this #ash22 abstract: 
The Weill Cornell Medicine Lymphoma Program seeks to enable people with lymphoma to have the best possible clinical outcome. https://t.co/VB4txzzqth